Production of interleukin-12 by murine macrophages in response to bacterial peptidoglycan

Infection and Immunity

Volumn 66, Issue 10, 1998, Pages 4947-4949

  Lawrence, Christine ^a   Nauciel, Charles ^a  

^a Faculte de Medecine de Paris Ouest   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BACILLUS MEGATERIUM; BACTERIAL INFECTION; CONTROLLED STUDY; CORYNEBACTERIUM; HOST RESISTANCE; IMMUNE RESPONSE; MACROPHAGE; MICROCOCCUS LUTEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0031684057     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.10.4947-4949.1998     Document Type: Article

References (33)

1. Adam, A., J.-F. Petit, P. Lefrancier, andE. Lederer. 1981. Muramyl peptides. Chemical structure, biological activity and mechanism of action. Mol. Cell. Biochem. 41:27-47.
2. Biron, C. A., and R. T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485-496.
3. + T cells. J. Immunol. 156:1458-1468.
4. Chong, C., K. L. Bost, andJ. D. Clemets. 1996. Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect. Immun. 64:1154-1160.
5. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, andI. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423-432.
6. Damais, C., C. Bona, L. Chedid, J. Fleck, C. Nauciel, andJ. P. Martin. 1975 Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity. J. Immunol. 115:268-271.
7. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, andG. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398.
8. Dziarski, R. 1980. Polyclonal activation of immunoglobulin secretion in B lymphocytes induced by staphylococcal peptidoglycan. J. Immunol. 125:2478-2483.
9. Dziarski, R. 1986. Effects of peptidoglycan on the cellular components of the immune system, p. 229-247. In P. H. Seidl and K. H. Schleifer (ed.), Biological properties of peptidoglycan. Walter de Gruyter, Berlin, Germany.
10. Goguel, A.-F., G. Lespinats, andC. Nauciel. 1982. Peptidoglycans extracted from gram-positive bacteria: expression of antitumor activity according to peptide structure and route of injection. J. Natl. Cancer Inst. 68:657-663.
11. Guenounou, M., A.-F. Goguel, andC. Nauciel. 1982. Study of adjuvant and mitogenic activities of bacterial peptidoglycans with different structures. Ann. Immunol. (Paris) 133D:3-13.
12. Gupta, D., T. N. Kirkland, S. Viriyakosol, andR. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:23310-23316.
13. Heumann, D., C. Barras, A. Severin, M. P. Glauser, andA. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62:2715-2721.
14. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
15. Kotani, S., Y. Watanabe, F. Kinoshita, K. Kato, K. H. Schleifer, andH. R. Perkins. 1977. Inabilities as an immunoadjuvant of cell walls of the group B peptidoglycan types and those of arthrobacters. Biken J. 20:1-4.
16. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, andM. K. Gately. 1996. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4:471-481.
17. Mahon, B. P., M. S. Ryan, F. Griffin, andK. H. G. Mills. 1996. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64:5295-5301.
18. Mastroeni, P., J. A. Harrison, J. A. Chabalgoity, andC. E. Hormaeche. 1996. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect. Immun. 64:189-196.
19. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7:145-173.
20. Müller, G., J. Saloga, T. Germann, G. Schuler, J. Knop, andA. H. Enk. 1995. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J. Immunol. 155:4661-4668.
21. Nauciel, C., J. Fleck, M. Mock, andJ. P. Martin. 1973. Activité adjuvante de fractions monomériques de peptidoglycanes bactériens dans l'hypersensibilité de type retardé. C. R. Acad. Sci. Ser. D 277:2841-2844.
22. Nauciel, C., J. Fleck, J. P. Martin, M. Mock, andH. Nguyen-Huy. 1974. Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response. Eur. J. Immunol. 4:352-356.
23. Pie, S., P. Truffa-Bachi, M. Pla, andC. Nauciel. 1997. Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance. Infect. Immun. 65:4509-4514.
24. Saunders, B. M., Y. Zhan, andC, Cheers. 1995. Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection. Infect. Immun. 63:4011-4015.
25. Schleifer, K. H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36:407-477.
26. Skeen, M. J., M. A. Miller, T. M. Shinnick, andH. K. Ziegler. 1996. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156:1196-1206.
27. Timmerman, C. P., E. Mattsson, L. Martinez-Martinez, L. de Graaf, J. A. G. van Strijp, H. A. Verbrugh, J. Verhoef, andA. Fleer. 1993. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect. Immun. 61:4167-4172.
28. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
29. Tripp, C. S., S. F. Wolf, andE. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor a are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90: 3725-3729.
30. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, andE. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SC1D and C.B-17 mice. Reversal by IFN-γ. J. Immunol. 152:1883-1887.
31. Vacheron, F., M. Guenounou, andC. Nauciel. 1983. Induction of interleukin 1 secretion by adjuvant-active peptidoglycans. Infect. Immun. 42:1049-1054.
32. Vacheron, F., M. Guenounou, H. Zinbi, andC. Nauciel. 1986. Release of a cytotoxic factor by macrophages stimulated with adjuvant-active peptidoglycans. J. Natl. Cancer Inst. 77:549-553.
33. Zhan, Y., and C. Cheers. 1495. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63:1387-1390.